Andrea Farolfi
Overview
Explore the profile of Andrea Farolfi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
852
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brusa I, Cabitza V, Emiliani S, Malizia C, Fortunati E, Zanoni L, et al.
Nucl Med Biol
. 2025 Feb;
140-141:108974.
PMID: 39999572
Background: Due to the increasing application of the fibroblast activation protein (FAP) targeting radiotracer [Ga]Ga-FAPI-46 in cancer diagnostics by PET/CT, there is a need for a convenient way for routine...
2.
Ells Z, Ludwig V, Weiner A, Kimura K, Farolfi A, Chamie K, et al.
Methods
. 2025 Feb;
236:10-16.
PMID: 39988309
Introduction: Surgeons commonly use cross sectional images to plan and prepare for surgical procedures. However, cognitively translating 2D images to surgical settings can be difficult and lead to sub-optimal resections....
3.
Laudicella R, Bauckneht M, Burger I, Cacciola A, Fanti S, Farolfi A, et al.
Eur J Nucl Med Mol Imaging
. 2025 Feb;
PMID: 39934300
Purpose: Conventional systemic therapies are valuable options in prostate cancer (PCa); however, such treatments can determine adverse events and toxicity. The observed improvement in overall survival, coupled with PSA reduction...
4.
Di Giorgio A, Rapa M, Civollani S, Farolfi A, Fanti S
Curr Oncol
. 2025 Jan;
32(1.
PMID: 39851925
Focal therapy offers a promising approach for treating localized prostate cancer (PC) with minimal invasiveness and potential cost benefits. High-intensity focused ultrasound (HIFU) and brachytherapy (BT) are among these options...
5.
Dalmonte S, Cocozza M, Cuicchi D, Remondini D, Faggioni L, Castellucci P, et al.
Heliyon
. 2025 Jan;
11(1):e41404.
PMID: 39839519
Background: The modern approach to treating rectal cancer, which involves total mesorectal excision directed by imaging assessments, has significantly enhanced patient outcomes. However, locally recurrent rectal cancer (LRRC) continues to...
6.
Zamboglou C, Staus P, Wolkewitz M, Peeken J, Ferentinos K, Strouthos I, et al.
Eur Urol Focus
. 2024 Nov;
PMID: 39609244
Background And Objective: Up to 50% of patients with prostate cancer experience prostate-specific antigen (PSA) relapse following primary radical prostatectomy (RP). Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) is...
7.
Lamberti R, Ferraro S, Farolfi A, Ghezzi M, Zirpoli S, Munari A, et al.
Ital J Pediatr
. 2024 Nov;
50(1):243.
PMID: 39538243
Background: Non-cystic fibrosis (non-CF) bronchiectasis (BE) is defined as a clinical syndrome of recurrent, persistent wet cough and abnormal bronchial dilatation on chest High Resolution Computed Tomography (HRCT) scans. The...
8.
Nanni C, Farolfi A, Castellucci P, Fanti S
Semin Nucl Med
. 2024 Nov;
55(1):31-40.
PMID: 39516095
Positron Emission Tomography (PET) is a crucial imaging modality in oncology, providing functional insights by detecting metabolic activity in tissues. Total-body (TB) PET and large field-of-view PET have emerged as...
9.
Zagni F, Vetrone L, Farolfi A, Vadala M, Lodi Rizzini E, Golemi A, et al.
J Nucl Med
. 2024 Nov;
65(12):1848-1849.
PMID: 39510584
No abstract available.
10.
PSMA PET-targeted Biopsy for Prostate Cancer Diagnosis: Initial Experience From a Multicenter Cohort
Checcucci E, Bauckneht M, Cisero E, Volpi G, Rizzo A, Zattoni F, et al.
Urology
. 2024 Oct;
196:178-185.
PMID: 39426743
Objective: To describe the initial experience with PSMA-PET/CT-guided biopsy in European referral centres. Methods: This multicenter observational cohort study was endorsed by the Young Academic Urologist (YAU) Prostate Cancer Group...